CryoCath to Hold First Quarter 2008 Conference Call and Webcast

                      Toronto Stock Exchange Symbol: CYT

    MONTREAL, Feb. 7 /CNW/ - CryoCath (TSX: CYT), will hold a conference call
to discuss its first quarter 2008 financial results at 4:30 p.m. (Eastern
Time) on Thursday, February 14, 2008. The Company will report its results in a
press release to be issued at 4:00 p.m. on Thursday, February 14.

    DATE:              Thursday, February 14, 2008

    TIME:              4:30 p.m., Eastern Standard Time

    TAPED REPLAY:      416-640-1917 or 1-877-289-8525 (Available until
                       February 21, 2008)

    REFERENCE NUMBER:  21262307

    WEBCAST:           A live audio webcast of the call will be available at
              Webcast attendees are welcome to
                       listen to the conference in real-time or on-demand at
                       their convenience. The webcast will be archived for
                       365 days. Please connect to this website at least
                       15 minutes prior to the conference call to ensure
                       adequate time for any software download that may be
                       needed to hear the webcast.

    About CryoCath

    CryoCath - - is a medical technology company that leads
the world in cryotherapy products to treat cardiovascular disease. With a
priority focus on providing physicians with a complete solution of catheter
products to treat cardiac arrhythmias, CryoCath has multiple products approved
in the U.S., across Europe and several ROW countries. The Company is
developing additional products to expand its pipeline of products to treat
cardiac arrhythmias.

    This press release includes "forward-looking statements" that are subject
to risks and uncertainties, including with respect to the timing of regulatory
trials and their outcome. For information identifying legislative or
regulatory, economic, climatic, currency, technological, competitive and other
important factors that could cause actual results to differ materially from
those anticipated in the forward looking statements, see CryoCath's annual
report available at under the heading Risks and Uncertainties in
the Management's Discussion and Analysis section.

    %SEDAR: 00015053EF

For further information:

For further information: visit our website at, or
contact: Michael Moore, Investor Relations, Phone: (416) 815-0700 ext. 241,
Fax: (416) 815-0080, E-mail:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890